Hard to put a timeline/price on any speculative investment. Note the wording investment and not trade.
My perspective is there are two possibily extremely valuable and lucrative paths they are on in the near term. OSA drug program and Epilepsy/Pain drug program.
The OSA program has some funding set-up and pieces in place it appears. Their approach is logical and hopefully the new technology can overcome past hinderances. It makes sense that it very well could and will, however needs proven. Maybe they are waiting on further patent news, or FDA or additional funding or ??? or maybe we will hear something soon too.
The Epilepsy/Pain progress is substantial, IMO. Google search the candidate, review the reports and listen to the interviews. Something more than a peanut farm is brewing with this. Odds of success are always low in drug development, but their current positive progress certainly has increased their chances significantly. Success on this path, IMO, will make this one of the most valuable OTC pharma historically. How long to wrap up the NIH final trials? Months, Quarters? How much dilution is left? Are there big pharmas now, "purse strings" in the mix?
Success is surely not guaranteed. Timing is unknown. But I am in the camp you do just accumulate for the long haul. Whether days or months or quarters down the road. Steps taken and noted in the filings appear to be positioning for success, although such is never guaranteed. GLTA.
News 
Market Data 
Discover 
AI
